B-cell receptor

The B-cell receptor or BCR is a transmembrane receptor protein located on the outer surface of B cells. The receptor's binding moiety is composed of a membrane-bound antibody that, like all antibodies, has a unique and randomly determined antigen-binding site (see V(D)J recombination). When a B cell is activated by its first encounter with an antigen that binds to its receptor (its "cognate antigen"), the cell proliferates and differentiates to generate a population of antibody-secreting plasma B cells and memory B cells. The B cell receptor (BCR) has two crucial functions upon interaction with the antigen. One function is signal transduction, involving changes in receptor oligomerization. The second function is to mediate internalization for subsequent processing of the antigen and presentation of peptides to helper T cells. BCR functions are required for normal antibody production, and defects in BCR signal transduction may lead to immunodeficency, and B-cell malignancy.

Podcasts:

PLAYLIST TIME:

Latest News for: b-cell receptor

Edit

Researchers find mechanisms that may lead to inflammatory bowel disease

Suryaa 23 Mar 2025
White blood cells in the GI tract known as intraepithelial lymphocytes express the gamma delta T cell receptor (gamma delta IELs), which prevent infection and provide surveillance for the intestinal barrier.
Edit

NIH researchers develop eye drops that slow vision loss in animals

NIH 21 Mar 2025
PEDF helps preserve cells in the eye’s retina ... Progressive loss of photoreceptor cells leads to vision loss and eventually blindness ... These small peptides can move through eye tissues to bind with PEDF receptor proteins on the surface of the retina.
Edit

New MERS-Related Coronavirus Discovered In Brazilian Bats – But Can It Infect Humans?

IFL Science 21 Mar 2025
... spike protein [which binds to mammalian cells to start an infection] suggesting potential interaction with the receptor used by MERS-CoV,” said the study’s first author, Bruna Stefanie Silvério.
Edit

Sickle Cell Disease Pipeline 2025 Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | ...

GetNews 21 Mar 2025
Sickle Cell Disease Overview ... Sickle Cell Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Edit

Bharat Biotech launches India's only integrated cell, gene therapy, and viral production facility

Beijing News 20 Mar 2025
... system modulation, and long-term cell survival ... My lab has initiated a pioneering collaboration with Bharat Biotech to develop next-generation CAR (chimeric antigen receptor) cell therapies using AI.
Edit

Spring signs never get old

The Gazette Cedar Rapids 20 Mar 2025
By early March my central nervous system receptor cells crave the stimulation that can only be provided by the crisp toink of a gamefish inhaling a tungsten jig at the end of stretchless braided line running through the eyes of a sensitive rod ... .
Edit

PD-1 and PD-L1 Inhibitors Market: Trends, Growth, and Future Prospects

Pharmiweb 20 Mar 2025
Programmed cell death protein 1 (PD-1) and its ligand, PD-L1, are crucial immune checkpoints that regulate the body's immune response ... PD-1 is a receptor found on T-cells, while PD-L1 is its ligand expressed on various cells, including cancer cells.
Edit

Artificial Sweeteners May Directly Affect Heart Muscle, Study Finds

The Epoch Times 19 Mar 2025
The study revealed that these receptors—similar ... The new study is the first to identify sweet taste receptors (STRs), called TAS1R2 and TAS1R3, on the surface of heart muscle cells.
Edit

Metastatic Breast Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 19 Mar 2025
PMD-026 is a targeted oral agent designed to kill tumor cells in metastatic breast cancer ... robust receptor occupancy. Oestrogen encourages HR-positive breast cancer cells to grow by attaching to the ER.
Edit

Hypoxia Makes the Gut Healthy

The Scientist 19 Mar 2025
Gut bacteria produce metabolites that bind to intestinal cell receptors and signal maintenance of low oxygen levels ... of mice with colitis by binding to a receptor on the gut epithelial cells.
Edit

Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy

ACCESSWIRE 18 Mar 2025
APVO603 is a novel bispecific antibody designed to enhance anti-tumor immune responses through dual targeting of 4-1BB (CD137) and OX40 (CD134), two key co-stimulatory receptors involved in T cell and NK cell activation.
Edit

Semaglutide reduces brain inflammation and improves memory in an Alzheimer’s model

PsyPost 17 Mar 2025
It belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists, which help regulate blood sugar and appetite ... Alzheimer’s disease gradually damages nerve cells in the brain, leading to memory loss and cognitive decline.
Edit

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition

Pharmiweb 17 Mar 2025
To achieve this, the Company is building world-class cell therapy capabilities and advancing a broad pipeline of cell therapies, enabled by technologies including chimeric antigen receptor T-cells ...
Edit

NK Cell Therapy Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, IND, NDA Approval, ...

GetNews 17 Mar 2025
In contrast, T-cell receptor (TCR)-engineered NK cells offer distinct advantages, enabling the recognition of intracellular antigens with lower activation thresholds and eliminating the risk of receptor mispairing.
Edit

Brain region identified as key controller of aggression

PsyPost 17 Mar 2025
“When mice transition from investigating an animal to attacking, activity in a population of cells which express estrogen receptor 1 (ESR1) is heightened,” Aubry explained ... of nerve cells.
×